MEDICATION-ASSISTED TREATMENT ACCESS Summary

[Pages:5]California Opioid Legislation Update Quality Healthcare Concepts, Inc. June 28, 2018

MEDICATION-ASSISTED TREATMENT ACCESS

AB 349 McCarty (D-Sacramento)

Summary: Permits the Department of Health Care Services to annually establish and update the Drug-Medi-Cal statewide maximum allowable reimbursement rates by means of bulletins or similar instructions without being required to adopt regulations until July 1, 2020.

Sponsor: California Opioid Maintenance Providers

Location: Senate Appropriations

AB 2384 Arambula (D-Fresno)

Summary: bans prior authorization and other insurer barriers on prescriptions for medicationassisted treatment.

Sponsor: California Medical Association (CMA)

Opposition: America's Health Insurance Plans

Location: Senate Appropriations

AB 2487 McCarty (D-Sacramento)

Summary: gives physicians of choice of CME that can lead to prescribing opioids or CME on treating opioid addiction; currently physicians required to take first course that did and may still promote opioid addiction.

Support: California Chapter of the American College of Emergency Physicians (CA ACEP)

Location: Senate Appropriations (51-18 on assembly floor)

REHAB ACCESS

SB 275 Portantino (D-San Fernando Valley)

Summary: Requires the Department of Health Care Services (DHCS) to convene an expert panel to advise DHCS on the development of youth substance use disorder (SUD) treatment, early intervention, and prevention quality standards, as specified.

Support: California Society of Addiction Medicine (CSAM), Service Employee International Union (SEIU)

Location: Assembly Appropriations

SB 823 Hill (D-Palo Alto)

Summary: Requires the Department of Health Care Services (DHCS) to adopt the American Society of Addiction Medicine (ASAM) treatment criteria, or an equivalent evidence-based standard, as the minimum standard of care for licensed adult alcoholism or drug abuse recovery or treatment facilities (licensed treatment facilities)

Support: CSAM

Location: Assembly Appropriations

SB 992 Hernandez (D- San Gabriel Valley)

Summary: Requires all alcoholism and drug abuse recovery or treatment facilities (RTFs) certified or licensed by the Department of Health Care Services (DHCS) to disclose specified information to DHCS.

Support: California State Association of Counties (CSAC)

Location: Assembly Appropriations

NALOXONE ACCESS AB 2256 Santiago (D-Downtown L.A.)

Summary: Allows pharmacists to furnish naloxone to qualified law enforcement officers under certain conditions.

Support: CSAM, CA ACEP

Location: Senate Appropriations

AB 2760 Wood (D-Healdsburg)

Summary: Requires a prescriber to prescribe naloxone for a patient identified to be in an identified risk group. Requires a prescriber to provide education to patients receiving a naloxone prescription and to their households on overdose prevention and use of naloxone.

Support: CA Pharmacists Association, County Health Executives Assn of CA, Drug Policy Alliance, National Health Law Program, McKesson

Opposition: CMA, CA ACEP

Location: Senate Appropriations

OPIOID PRESCRIBING LIMITS

AB 1753 Low (D-Campbell)

Summary: Authorizes the Department of Justice to reduce or limit the number of printer vendors used to produce prescription pads.

Support: CA Association of Health Underwriters, CA District Attorneys Association, CA Life Sciences Association, CA Police Chiefs, Consumer Attorneys of CA, San Diego County Office of the District Attorney, Troy and Alana Pack Foundation

Location: Senate Appropriations

AB 1998 Rodriguez (D-Chino)

Summary: Requires every health care practitioner authorized to prescribe opioids classified as Schedule II and Schedule III to adopt a safe prescribing protocol. Requires opioid prescribers to offer naloxone prescription, under certain conditions. The State Department of Public Health to utilize data from CURES to report on progress toward to-be-specified opioid prescription reduction objectives.

Opposition: CA ACEP

Location: Senate Appropriations

AB 2783 O'Donnell (D-Long Beach)

Summary: Reconciles differences between California's controlled substance schedules and the corresponding federal controlled substance schedules.

Opposition: California Attorneys for Criminal Justice

Location: Senate Appropriations

AB 2789 Wood (D-Santa Rosa)

Summary: Requires that all health care practitioners authorized to issue prescriptions to be capable of electronically prescribing by January 1, 2020, and requires that all prescriptions for controlled substances be transmitted electronically beginning January 1, 2021, with exceptions.

Support: Medical Board of CA

Opposition: CMA

Location: Senate Appropriations

SB 1109 Bates (R-Laguna Hills)

Summary: Requires prescribers to take CME on the risks of addiction associated with the use of Schedule II controlled substances; requires various forms of public education on opioid risks.

Support: Office of the San Diego County District Attorney (sponsor), McKesson, CMA

Location: Assembly Appropriations

CURES AB 1751 Low (D-Campbell)

Summary: Authorizes the Department of Justice to enter into an agreement with an entity to share opioid prescribing data across state lines. Support (partial list): Biocom, CA Police Chiefs, CA State Sheriff's Association, CA Pharmacists Association Opposition: CMA Location: Senate Appropriations AB 1752 Low (D-Campbell) Summary: Requires all Schedule V controlled substances like cough syrups containing opioids to be monitored in CURES. Support: CA Police Chiefs, CA State Sheriff's Assn. Opposition: American Civil Liberties Association (ACLU) Location: Senate Appropriations AB 2086 Gallagher (R-Chico) Summary: Allows prescribers of controlled substances to review a list of patients for whom they are listed as the prescriber in CURES. Support: CSAM, CMA, CA Police Chiefs Association, McKesson Location: Senate Appropriations

PRESCRIPTION DRUG DISPOSAL SB 212 Jackson (D-Santa Barbara)

Summary: Requires drug-makers to establish drug take-back programs; bans future county drug take-back ordinances. PhRMA supports; but some drug-makers oppose. Support: California Product Stewardship Council Opposition: California Retailers Association, National Association of Chain Drug Stores Location: Senate Appropriations

 ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download